\contentsline {chapter}{\numberline {1}Introduction}{1}{chapter.1}
\contentsline {section}{\numberline {1.1}Cancer Research in the Post-Genomic Era}{1}{section.1.1}
\contentsline {subsection}{\numberline {1.1.1}Cancer as a Global Health Concern}{2}{subsection.1.1.1}
\contentsline {subsubsection}{\numberline {1.1.1.1}Genetics and Molecular Biology in Cancers}{3}{subsubsection.1.1.1.1}
\contentsline {subsection}{\numberline {1.1.2}The Human Genome Revolution}{5}{subsection.1.1.2}
\contentsline {subsubsection}{\numberline {1.1.2.1}The First Human Genome Sequence}{5}{subsubsection.1.1.2.1}
\contentsline {subsubsection}{\numberline {1.1.2.2}Impact of Genomics}{6}{subsubsection.1.1.2.2}
\contentsline {subsection}{\numberline {1.1.3}Technologies to Enable Genetics Research}{7}{subsection.1.1.3}
\contentsline {subsubsection}{\numberline {1.1.3.1}DNA Sequencing and Genotyping Technologies}{7}{subsubsection.1.1.3.1}
\contentsline {subsubsection}{\numberline {1.1.3.2}Microarrays and Quantitative Technologies}{8}{subsubsection.1.1.3.2}
\contentsline {subsubsection}{\numberline {1.1.3.3}Massively Parallel ``Next Generation'' Sequencing}{9}{subsubsection.1.1.3.3}
\contentsline {subsubsubsection}{\numberline {1.1.3.3.1}Molecular Profiling with Genomics Technology}{10}{subsubsubsection.1.1.3.3.1}
\contentsline {subsubsubsection}{\numberline {1.1.3.3.2}Established Sequencing Technologies}{11}{subsubsubsection.1.1.3.3.2}
\contentsline {subsubsubsection}{\numberline {1.1.3.3.3}Emerging Sequencing Technologies}{12}{subsubsubsection.1.1.3.3.3}
\contentsline {subsubsection}{\numberline {1.1.3.4}Bioinformatics as Interdisciplinary Genomic Analysis}{14}{subsubsection.1.1.3.4}
\contentsline {subsection}{\numberline {1.1.4}Follow-up Large-Scale Genomics Projects}{14}{subsection.1.1.4}
\contentsline {subsection}{\numberline {1.1.5}Cancer Genomes}{15}{subsection.1.1.5}
\contentsline {subsubsection}{\numberline {1.1.5.1}The Cancer Genome Atlas Project}{16}{subsubsection.1.1.5.1}
\contentsline {subsubsection}{\numberline {1.1.5.2}The International Cancer Genome Consortium}{17}{subsubsection.1.1.5.2}
\contentsline {subsubsubsection}{\numberline {1.1.5.2.1}Findings from Cancer Genomes}{17}{subsubsubsection.1.1.5.2.1}
\contentsline {subsubsubsection}{\numberline {1.1.5.2.2}Genomic Comparisons Across Cancer Tissues}{19}{subsubsubsection.1.1.5.2.2}
\contentsline {subsubsubsection}{\numberline {1.1.5.2.3}Cancer Genomic Data Resouces}{20}{subsubsubsection.1.1.5.2.3}
\contentsline {subsection}{\numberline {1.1.6}Genomic Cancer Medicine}{20}{subsection.1.1.6}
\contentsline {subsubsection}{\numberline {1.1.6.1}Cancer Genes and Driver Mutations}{21}{subsubsection.1.1.6.1}
\contentsline {subsubsection}{\numberline {1.1.6.2}Personalised or Precision Cancer Medicine}{22}{subsubsection.1.1.6.2}
\contentsline {subsubsubsection}{\numberline {1.1.6.2.1}Molecular Diagnostics and Pan-Cancer Medicine}{22}{subsubsubsection.1.1.6.2.1}
\contentsline {subsubsection}{\numberline {1.1.6.3}Targeted Therapeutics and Pharmacogenomics}{23}{subsubsection.1.1.6.3}
\contentsline {subsubsubsection}{\numberline {1.1.6.3.1}Targeting Oncogenic Driver Mutations}{23}{subsubsubsection.1.1.6.3.1}
\contentsline {subsubsection}{\numberline {1.1.6.4}Systems and Network Biology}{24}{subsubsection.1.1.6.4}
\contentsline {subsubsubsection}{\numberline {1.1.6.4.1} Network Medicine, and Polypharmacology}{27}{subsubsubsection.1.1.6.4.1}
\contentsline {section}{\numberline {1.2}A Synthetic Lethal Approach to Cancer Medicine}{28}{section.1.2}
\contentsline {subsection}{\numberline {1.2.1}Synthetic Lethal Genetic Interactions}{28}{subsection.1.2.1}
\contentsline {subsection}{\numberline {1.2.2}Synthetic Lethal Concepts in Genetics}{29}{subsection.1.2.2}
\contentsline {subsection}{\numberline {1.2.3}Studies of Synthetic Lethality}{30}{subsection.1.2.3}
\contentsline {subsubsection}{\numberline {1.2.3.1}Synthetic Lethal Pathways and Networks}{30}{subsubsection.1.2.3.1}
\contentsline {subsubsubsection}{\numberline {1.2.3.1.1}Conservation and Evolution of Synthetic Lethality}{31}{subsubsubsection.1.2.3.1.1}
\contentsline {subsection}{\numberline {1.2.4}Synthetic Lethal Concepts in Cancer}{32}{subsection.1.2.4}
\contentsline {subsection}{\numberline {1.2.5}Clinical Impact of Synthetic Lethality in Cancer}{33}{subsection.1.2.5}
\contentsline {subsection}{\numberline {1.2.6}High{}-throughput Screening for Synthetic Lethality}{35}{subsection.1.2.6}
\contentsline {subsubsection}{\numberline {1.2.6.1}Examples of Synthetic Lethal Screens}{37}{subsubsection.1.2.6.1}
\contentsline {subsection}{\numberline {1.2.7}Computational Prediction of Synthetic Lethality}{40}{subsection.1.2.7}
\contentsline {subsubsection}{\numberline {1.2.7.1}Bioinformatics approaches to gene interactions}{40}{subsubsection.1.2.7.1}
\contentsline {subsubsection}{\numberline {1.2.7.2}Comparative genomics}{41}{subsubsection.1.2.7.2}
\contentsline {subsubsection}{\numberline {1.2.7.3}Analysis and modelling of protein data}{44}{subsubsection.1.2.7.3}
\contentsline {subsubsection}{\numberline {1.2.7.4}Differential gene expression}{46}{subsubsection.1.2.7.4}
\contentsline {subsubsection}{\numberline {1.2.7.5}Data mining and machine learning}{47}{subsubsection.1.2.7.5}
\contentsline {subsubsection}{\numberline {1.2.7.6}Bimodality}{50}{subsubsection.1.2.7.6}
\contentsline {subsubsection}{\numberline {1.2.7.7}Rationale for further development}{50}{subsubsection.1.2.7.7}
\contentsline {section}{\numberline {1.3}E-cadherin as a Synthetic Lethal Target}{51}{section.1.3}
\contentsline {subsection}{\numberline {1.3.1}The \textit {CDH1} gene and it's Biological Functions}{51}{subsection.1.3.1}
\contentsline {subsubsection}{\numberline {1.3.1.1}Cytoskeleton}{51}{subsubsection.1.3.1.1}
\contentsline {subsubsection}{\numberline {1.3.1.2}Extracellular and Tumour Micro-Environment}{52}{subsubsection.1.3.1.2}
\contentsline {subsubsection}{\numberline {1.3.1.3}Cell-Cell Adhesion and Signalling}{52}{subsubsection.1.3.1.3}
\contentsline {subsection}{\numberline {1.3.2}\textit {CDH1} as a Tumour (and Invasion) Suppressor}{52}{subsection.1.3.2}
\contentsline {subsubsection}{\numberline {1.3.2.1}Breast Cancers and Invasion}{53}{subsubsection.1.3.2.1}
\contentsline {subsection}{\numberline {1.3.3}Hereditary Diffuse Gastric Cancer and Lobular Breast Cancer}{53}{subsection.1.3.3}
\contentsline {subsection}{\numberline {1.3.4}Somatic Mutations}{54}{subsection.1.3.4}
\contentsline {subsubsection}{\numberline {1.3.4.1}Mutation Rate}{54}{subsubsection.1.3.4.1}
\contentsline {subsubsection}{\numberline {1.3.4.2}Co-occuring Mutations}{55}{subsubsection.1.3.4.2}
\contentsline {subsection}{\numberline {1.3.5}Models of \textit {CDH1} loss in cell lines}{56}{subsection.1.3.5}
\contentsline {section}{\numberline {1.4}Summary and Research Direction of Thesis}{56}{section.1.4}
\contentsline {chapter}{\numberline {2}Methods, Techniques, and Resources}{60}{chapter.2}
\contentsline {section}{\numberline {2.1}Bioinformatics Resources to Enable Genomics Research}{60}{section.2.1}
\contentsline {subsection}{\numberline {2.1.1}Public Data and Software Packages}{60}{subsection.2.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.1}Cancer Genome Atlas Data}{61}{subsubsection.2.1.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.2}Reactome and Annotation Data}{62}{subsubsection.2.1.1.2}
\contentsline {section}{\numberline {2.2}Data Handling}{62}{section.2.2}
\contentsline {subsection}{\numberline {2.2.1}Normalisation (voom)}{62}{subsection.2.2.1}
\contentsline {subsection}{\numberline {2.2.2}Sample Triage}{63}{subsection.2.2.2}
\contentsline {subsection}{\numberline {2.2.3}Pathway Metagenes and the Singular Value Decomposition}{64}{subsection.2.2.3}
\contentsline {subsubsection}{\numberline {2.2.3.1}Candidate Triage and Integration with Screen Data}{65}{subsubsection.2.2.3.1}
\contentsline {section}{\numberline {2.3}Techniques}{65}{section.2.3}
\contentsline {subsection}{\numberline {2.3.1}Statistical Procedures and Tests}{66}{subsection.2.3.1}
\contentsline {subsection}{\numberline {2.3.2}Gene Set Over-representation Analysis}{67}{subsection.2.3.2}
\contentsline {subsection}{\numberline {2.3.3}Clustering}{67}{subsection.2.3.3}
\contentsline {subsection}{\numberline {2.3.4}Heatmap}{67}{subsection.2.3.4}
\contentsline {subsection}{\numberline {2.3.5}Modeling and Simulations}{68}{subsection.2.3.5}
\contentsline {subsubsection}{\numberline {2.3.5.1}Receiver Operating Characteristic (Performance)}{69}{subsubsection.2.3.5.1}
\contentsline {subsection}{\numberline {2.3.6}Resampling Analysis}{69}{subsection.2.3.6}
\contentsline {section}{\numberline {2.4}Pathway Structure Methods}{70}{section.2.4}
\contentsline {subsection}{\numberline {2.4.1}Network and Graph Analysis}{70}{subsection.2.4.1}
\contentsline {subsection}{\numberline {2.4.2}Sourcing Graph Structure Data}{71}{subsection.2.4.2}
\contentsline {subsection}{\numberline {2.4.3}Constructing Pathway Subgraphs}{71}{subsection.2.4.3}
\contentsline {subsection}{\numberline {2.4.4}Network Analysis Metrics}{72}{subsection.2.4.4}
\contentsline {section}{\numberline {2.5}Implementation}{73}{section.2.5}
\contentsline {subsection}{\numberline {2.5.1}Computational Resources and Linux Utilities}{73}{subsection.2.5.1}
\contentsline {subsection}{\numberline {2.5.2}R Language and Packages}{74}{subsection.2.5.2}
\contentsline {subsection}{\numberline {2.5.3}High Performance and Parallel Computing}{77}{subsection.2.5.3}
\contentsline {chapter}{\numberline {3}Methods Developed During Thesis}{78}{chapter.3}
\contentsline {section}{\numberline {3.1}A Synthetic Lethal Detection Methodology}{79}{section.3.1}
\contentsline {section}{\numberline {3.2}Synthetic Lethal Simulation and Modelling}{81}{section.3.2}
\contentsline {subsection}{\numberline {3.2.1}A Model of Synthetic Lethality in Expression Data}{81}{subsection.3.2.1}
\contentsline {subsection}{\numberline {3.2.2}Simulation Procedure}{85}{subsection.3.2.2}
\contentsline {section}{\numberline {3.3}Detecting Simulated Synthetic Lethal Partners}{87}{section.3.3}
\contentsline {subsection}{\numberline {3.3.1}Multivariate Normal Simulation of Synthetic lethality}{88}{subsection.3.3.1}
\contentsline {subsubsection}{\numberline {3.3.1.1}Simulation with Directional Testing}{88}{subsubsection.3.3.1.1}
\contentsline {subsubsection}{\numberline {3.3.1.2}Simulation with Query-Correlated Pathways}{88}{subsubsection.3.3.1.2}
\contentsline {subsubsection}{\numberline {3.3.1.3}Simulated Expression Heatmaps}{88}{subsubsection.3.3.1.3}
\contentsline {subsection}{\numberline {3.3.2}Replication Simulation Heatmap}{88}{subsection.3.3.2}
\contentsline {section}{\numberline {3.4}Graph Structure Methods}{89}{section.3.4}
\contentsline {subsection}{\numberline {3.4.1}Upstream and Downstream Gene Detection}{89}{subsection.3.4.1}
\contentsline {subsubsection}{\numberline {3.4.1.1}Permutation Analysis for Statistical Significance}{90}{subsubsection.3.4.1.1}
\contentsline {subsubsection}{\numberline {3.4.1.2}Ranking Based on Biological Context}{90}{subsubsection.3.4.1.2}
\contentsline {subsection}{\numberline {3.4.2}Simulating Gene Expression from Graph Structures}{91}{subsection.3.4.2}
\contentsline {section}{\numberline {3.5}Customised Functions and Packages Developed}{96}{section.3.5}
\contentsline {subsection}{\numberline {3.5.1}Synthetic Lethal Interaction Prediction Tool}{96}{subsection.3.5.1}
\contentsline {subsection}{\numberline {3.5.2}Data Visualisation}{97}{subsection.3.5.2}
\contentsline {subsection}{\numberline {3.5.3}Extensions to the iGraph Package}{97}{subsection.3.5.3}
\contentsline {subsubsection}{\numberline {3.5.3.1}Sampling Simulated Data from Graph Structures}{99}{subsubsection.3.5.3.1}
\contentsline {subsubsection}{\numberline {3.5.3.2}Plotting Directed Graph Structures}{99}{subsubsection.3.5.3.2}
\contentsline {subsubsection}{\numberline {3.5.3.3}Computing Information Centrality}{99}{subsubsection.3.5.3.3}
\contentsline {subsubsection}{\numberline {3.5.3.4}Testing Pathway Structure with Permutation Testing}{100}{subsubsection.3.5.3.4}
\contentsline {subsubsection}{\numberline {3.5.3.5}Metapackage to Install iGraph Functions}{100}{subsubsection.3.5.3.5}
\contentsline {chapter}{\numberline {4}Synthetic Lethal Analysis of Gene Expression Data}{102}{chapter.4}
\contentsline {section}{\numberline {4.1}Abstract}{102}{section.4.1}
\contentsline {section}{\numberline {4.2}Aims and Significance}{103}{section.4.2}
\contentsline {section}{\numberline {4.3}Background}{104}{section.4.3}
\contentsline {section}{\numberline {4.4}Background}{109}{section.4.4}
\contentsline {section}{\numberline {4.5}Sourcing TCGA data}{110}{section.4.5}
\contentsline {section}{\numberline {4.6}Quality checking}{110}{section.4.6}
\contentsline {section}{\numberline {4.7}Global Synthetic Lethality}{110}{section.4.7}
\contentsline {section}{\numberline {4.8}CDH1 Analysis with Subgroups}{111}{section.4.8}
\contentsline {section}{\numberline {4.9}Cell Line Analysis}{111}{section.4.9}
\contentsline {section}{\numberline {4.10}Mutation, Copy Number, and Methylation}{111}{section.4.10}
\contentsline {section}{\numberline {4.11}ANOVA of Expression Predictors}{112}{section.4.11}
\contentsline {section}{\numberline {4.12}Mutation Analysis, Pathway Expression, and Metagene Synthetic Lethality}{113}{section.4.12}
\contentsline {section}{\numberline {4.13}Data clean up, gene SL, and pathway SL}{114}{section.4.13}
\contentsline {section}{\numberline {4.14}Overview of Challenges}{115}{section.4.14}
\contentsline {section}{\numberline {4.15}Comparison of gene SL predictions and siRNA screen candidates}{116}{section.4.15}
\contentsline {section}{\numberline {4.16}Permutation or Re-Sampling of genes for pathway enrichment.}{117}{section.4.16}
\contentsline {section}{\numberline {4.17}Comparison of candidate SL Pathways}{118}{section.4.17}
\contentsline {section}{\numberline {4.18}Future Directions}{118}{section.4.18}
\contentsline {section}{\numberline {4.19}Hub Genes}{119}{section.4.19}
\contentsline {section}{\numberline {4.20}Metagene pathway expression}{119}{section.4.20}
\contentsline {section}{\numberline {4.21}Metagene synthetic lethality}{119}{section.4.21}
\contentsline {section}{\numberline {4.22}Replication in stomach cancer}{119}{section.4.22}
\contentsline {section}{\numberline {4.23}Important Results}{119}{section.4.23}
\contentsline {chapter}{\numberline {5}Pathway Structure of Synthetic Lethal Genes}{122}{chapter.5}
\contentsline {section}{\numberline {5.1}Abstract}{122}{section.5.1}
\contentsline {section}{\numberline {5.2}Background}{123}{section.5.2}
\contentsline {section}{\numberline {5.3}Reactome Network structure and Information Centrality as a measure of gene essentiality}{123}{section.5.3}
\contentsline {section}{\numberline {5.4}Synthetic lethal genes in synthetic lethal pathways}{124}{section.5.4}
\contentsline {section}{\numberline {5.5}Methods}{124}{section.5.5}
\contentsline {subsection}{\numberline {5.5.1}Sourcing graph structure data}{124}{subsection.5.5.1}
\contentsline {subsection}{\numberline {5.5.2}Constructing pathway subgraphs}{124}{subsection.5.5.2}
\contentsline {subsection}{\numberline {5.5.3}Centrality Measures}{124}{subsection.5.5.3}
\contentsline {subsection}{\numberline {5.5.4}upstream and downstream gene detection}{124}{subsection.5.5.4}
\contentsline {subsection}{\numberline {5.5.5}permutation analysis}{124}{subsection.5.5.5}
\contentsline {section}{\numberline {5.6}Centrality and connectivity of synthetic lethal genes}{124}{section.5.6}
\contentsline {section}{\numberline {5.7}Upstream or downstream synthetic lethal candidates}{124}{section.5.7}
\contentsline {section}{\numberline {5.8}Hierachical approach}{124}{section.5.8}
\contentsline {section}{\numberline {5.9}Discussion}{124}{section.5.9}
\contentsline {section}{\numberline {5.10}Conclusion}{124}{section.5.10}
\contentsline {chapter}{\numberline {6}Simulation and Modeling of Synthetic Lethal Pathways}{125}{chapter.6}
\contentsline {section}{\numberline {6.1}Abstract}{125}{section.6.1}
\contentsline {section}{\numberline {6.2}Background}{126}{section.6.2}
\contentsline {section}{\numberline {6.3}Simulations and Modelling Synthetic Lethality in Expression Data}{128}{section.6.3}
\contentsline {section}{\numberline {6.4}Developing a Synthetic Lethal detection methodology}{129}{section.6.4}
\contentsline {subsection}{\numberline {6.4.1}Testing Multivariate Normal Simulation of Synthetic lethality}{129}{subsection.6.4.1}
\contentsline {subsection}{\numberline {6.4.2}Receiver Operating Characteristic Curves}{130}{subsection.6.4.2}
\contentsline {subsection}{\numberline {6.4.3}Simulated Expression Heatmaps}{132}{subsection.6.4.3}
\contentsline {subsection}{\numberline {6.4.4}Replication Simulation Heatmap}{133}{subsection.6.4.4}
\contentsline {section}{\numberline {6.5}Simulation of synthetic lethality in graph structures}{136}{section.6.5}
\contentsline {subsection}{\numberline {6.5.1}Developing a multivariate normal expression from graph structures}{136}{subsection.6.5.1}
\contentsline {subsection}{\numberline {6.5.2}Simulations over simple graph structures}{136}{subsection.6.5.2}
\contentsline {subsubsection}{\numberline {6.5.2.1}Performance}{136}{subsubsection.6.5.2.1}
\contentsline {subsubsection}{\numberline {6.5.2.2}Synthetic lethality across graph stuctures}{136}{subsubsection.6.5.2.2}
\contentsline {subsubsection}{\numberline {6.5.2.3}Performance with inhibition links}{136}{subsubsection.6.5.2.3}
\contentsline {subsubsection}{\numberline {6.5.2.4}Performance with 20,000 genes}{136}{subsubsection.6.5.2.4}
\contentsline {subsection}{\numberline {6.5.3}Simulations over pathway-based graphs}{136}{subsection.6.5.3}
\contentsline {subsection}{\numberline {6.5.4}Comparing methods}{136}{subsection.6.5.4}
\contentsline {subsubsection}{\numberline {6.5.4.1}SLIPT and Chi-Squared}{136}{subsubsection.6.5.4.1}
\contentsline {subsubsubsection}{\numberline {6.5.4.1.1}Correlated query genes}{136}{subsubsubsection.6.5.4.1.1}
\contentsline {subsubsection}{\numberline {6.5.4.2}Correlation}{136}{subsubsection.6.5.4.2}
\contentsline {subsubsection}{\numberline {6.5.4.3}Linear models}{136}{subsubsection.6.5.4.3}
\contentsline {subsection}{\numberline {6.5.5}Developing a linear model predictor of synthetic lethality}{136}{subsection.6.5.5}
\contentsline {subsubsection}{\numberline {6.5.5.1}Linear models}{136}{subsubsection.6.5.5.1}
\contentsline {subsubsection}{\numberline {6.5.5.2}Polynomial models}{136}{subsubsection.6.5.5.2}
\contentsline {subsubsection}{\numberline {6.5.5.3}Conditioning}{136}{subsubsection.6.5.5.3}
\contentsline {subsubsection}{\numberline {6.5.5.4}SLIPTv2}{136}{subsubsection.6.5.5.4}
\contentsline {section}{\numberline {6.6}Significance}{136}{section.6.6}
\contentsline {section}{\numberline {6.7}Future Directions}{138}{section.6.7}
\contentsline {section}{\numberline {6.8}Conclusion}{139}{section.6.8}
\contentsline {chapter}{\numberline {7}Discussion}{140}{chapter.7}
\contentsline {chapter}{\numberline {8}Conclusion}{141}{chapter.8}
\contentsline {chapter}{\hbox to\@tempdima {\hfil }References}{142}{chapter.8}
\contentsline {chapter}{\numberline {A}Sample Correlation}{167}{appendix.A}
\contentsline {chapter}{\numberline {B}Software Used for Thesis}{169}{appendix.B}
\contentsline {chapter}{\numberline {C}Secondary Screen Data}{178}{appendix.C}
